Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.
Lee, W. J.; Lee, J. L.; Chang, S. E.; Lee, M. W.; Kang, Y. K.; Choi, J. H.; Moon, K. C.; Koh, J. K.; British Journal of Dermatology, 2009, vol. 161, issue 5, p 1045, ISSN 00070963. ISBN 13652133.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef